Who backs VeraDermics (NYS: MANE)?
26 investors| Investor | Type |
|---|---|
| Viking Global Investors | Asset manager |
| Connecticut Innovations | Venture capital |
| The Invus Group | PE / buyout |
| Osage University Partners | Venture capital |
| Marshall Wace | Hedge fund |
| SR One Capital Management | Other |
| Longitude Capital | Venture capital |
| Surveyor Capital | Hedge fund |
| Columbia Management | Asset manager |
| Suvretta Capital Management | Hedge fund |
| + 16 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
VeraDermics (NYS: MANE) investors
26 investors are on record for VeraDermics (NYS: MANE), including Viking Global Investors, Connecticut Innovations, The Invus Group and Osage University Partners. By type, the record holds 3 venture capital firms, 3 hedge funds and 2 asset managers. The Series C in Oct 2025 drew 10 investors.
Free account
More of VeraDermics (NYS: MANE) with a free account
- ·The complete investor list: 26 names
- ·Watch VeraDermics (NYS: MANE): the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 26 firms already write checks for companies like VeraDermics (NYS: MANE) in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View